Counter effects of Asiaticosids-D through putative neurotransmission on rotenone induced cerebral ganglionic injury in

Mamangam Subaraja, Arambakkam Janardhanam Vanisree

Erratum issuedOpen access · goldAbstract read

In one paragraph

Article in IBRO reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

0.3field-weighted citation impact, top 37% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

Erratum issued
Corrigendum to "Counter effects of Asiaticosids-D through neurotransmission pathway on rotenone induced cerebral ganglionic injury in2019

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Mamangam SubarajaDepartment of Biochemistry, University of Madras, Guindy Campus, Tamil Nadu, Chennai, 600 025, India.

Arambakkam Janardhanam VanisreeDepartment of Biochemistry, University of Madras, Guindy Campus, Tamil Nadu, Chennai, 600 025, India.

University of Madras · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Asiaticoside-D (AD) was shown to efficacy of ganglionic degenerated

Indexed as

5HT, serotoninAD’, Alzheimer diseaseAD, Asitiacoside-DALS, amyotrophic lateral sclerosisAsitiacoside-DCerebral ganglionsCGase, ceramide glycanaseCGs, cerebral ganglionsCNS, central nervous systemCOC, cytochrome C oxidaseDA, dopamineDAT, dopamine transporterDDs, degenerative diseasesGABARB, gama amninobutric acids -B receptorGDD, ganglionic degenerative diseaseHD, Huntington diseaseiGlu3, ionotropic glutamate receptor 3IL1β, interleukin-1betaInx-9, innexins-9Lumbricus terrestrisND-1, NADH dehydogenase subunite-1ND, neurodegenerationNeurotransmission pathwayNGF, nerve growth factorsnNOS, neuronal niticoxide synthaseNS, nervous systemNT, neurotransmissionNTs, neurotransmittersOAT, octopamine transporterP75NTR, P75 neurotrophin receptorPD, Parkinson’s diseaseRotenoneROT, rotenoneSERT, serotonin transporterTBH, tyramine beta-hydroxylaseTNF-α, tumour necrosis factor-αXPRL amide NP, XPR Lamide neuropeptide precursorΒeta-ARK2–3, β- adrenergic receptor kinase-2

Identifiers

PMID31193360

DOI10.1016/j.ibror.2019.04.003

PMCPMC6526298

OpenAlexW2943324937

What OpenQuestion holds

Textmetadata

LicenceCC BY-NC-ND

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.